Correspondence
Patients with COPD frequently are cared for by nonrespiratory specialists, and specialty might affect the approach to COPD. 1 , 2 The Linking Innovation and Knowledge in COPD (LINK) study comparatively assessed the clinical practice of three categories of Italian specialist physicians: 80 pneumologists, 81 geriatricians, and 82 internists completed an online questionnaire (e-Appendix 1) that explored these specialists' perceptions of COPD on the basis of individual experience and professional course. Data were analyzed by descriptive statistics, and discriminant analysis was used to compare the approach to COPD of the three specialist groups. 3 , 4 Pneumologists were more aware of specifi c pathophysiologic aspects of COPD, such as the clinical impact of dynamic hyperinfl ation (pneumologists, 86%; geriatricians, 54%; internists, 61%) and the phenotypic variants of COPD. Geriatricians more frequently performed multidimensional assessment of patients with COPD (geriatricians, 76.5%; pneumologists, 24%; internists, 28%). COPD-specifi c health status indexes were routinely used by 54% of pneumologists, 57% of geriatricians, and 45% of internists. Seventy-fi ve percent of geriatricians routinely assessed activities of daily living and instrumental activities of daily living compared with 35% of pneumologists and 39% of internists.
Results from the discriminant analysis are summarized in Table 1 . The fi rst discriminant function explained 92% of the variance and had a small Wilks l (ie, only a small proportion of the variance among groups is not explained by differences among groups). A high eigenvalue further testifi es to the strong discriminant power of function 1. The cross-tabulation of actual group membership as defi ned by the selection criteria and functional group membership resulting from the performance on the questionnaire are reported in Table 2 . The majority of geriatricians (84%) and pneumologists (71%) had concordant actual and functional group membership (ie, in their daily practice, they conformed to a highly prevalent group-specifi c pattern). The same was not true for internists, where only 39% behaved as internists, 40% as pneumologists, and 21% as geriatricians.
A specialty-related approach to COPD characterized the majority of pneumologists and geriatricians and was related to distinctive visions of physiopathology, health status, comorbidity, and modality of assessment of patients with COPD. The attitude of internists toward COPD was highly heterogeneous. Our fi ndings identify selected weaknesses and strengths of the various management styles and might suggest strategies to improve specialty practice as it pertains to COPD management. 
Procalcitonin vs Clinical and Chest Film Findings to Diagnose Community-Acquired Pneumonia in Patients With Acute Asthma or Acute Exacerbations of Chronic Bronchitis
To the Editor:
I read with interest the article by Dr Bafadhel et al 1 in a recent issue of CHEST (June 2011) on using procalcitonin levels to diagnose community-acquired pneumonia (CAP) in adults with acute exacerbations of chronic bronchitis (AECB) or asthma. The diagnostic signifi cance of procalcitonin depends on the clinical context. 2 However, the use of procalcitonin levels in diagnosing CAP in adults with acute asthma or AECB seems to be unnecessary.
Patients with asthma exacerbations who are ill enough to be seen in the ED have well-known clinical features. Patients presenting with asthma are afebrile with a chest radiograph showing hyperinfl ation but no pulmonary infi ltrates. Patients with AECB presenting to the ED are afebrile and have changes in their sputum (ie, volume, color, and tenacity). Unlike those with asthma, patients with AECB are prone to bacterial CAP. However, the chest radiograph readily differentiates AECB from CAP by the presence or absence of focal/segmental infi ltrates. In AECB, chest radiographic fi ndings are limited to peribronchial cuffi ng, but the radiographs are usually unremarkable. The diagnosis of bacterial CAP is based on the presence of fever, pulmonary symptoms, and a focal/segmental infi ltrate on chest radiograph. Viral CAPs on chest radiograph are clear or may show an accentuation of lung markings or bilateral patchy interstitial infi ltrates. Therefore, diagnosis of bacterial CAP in adults with acute asthma or AECB rests primarily on the presence of fever and chest radiograph infi ltrates compatible with bacterial CAP. 3 , 4 Patients with AECB are predisposed to develop Streptococcus pneumoniae, Haemophilus infl uenzae, and, particularly, Moraxella catarrhalis CAP. In contrast to AECB, bacterial CAP is a rare complication of an acute asthma exacerbation. Respiratory viruses are frequent triggers of acute asthma whereas Mycoplasma pneumoniae and Chlamydophila pneumoniae may trigger, exacerbate, or cause asthma. Procalcitonin levels are unelevated or mildly or moderately elevated with viral and atypical CAPs. With bacterial CAPs, procalcitonin levels are more highly elevated with bacteremic and lobar CAP. 3 , 4 In an era dominated by technologically driven diagnoses, we should not forget that the traditional clinical approach to diagnosing CAP still rests on history, physical examination, and chest radiographic fi ndings. This time-tested approach has not lost its clinical usefulness or accuracy. It has been said, and I agree, "All biomarkers have their weaknesses and strengths. None should be used alone; and none is anything more than an aid in the exercise of clinical judgement." 5 Procalcitonin levels add nothing except additional cost and possibly diagnostic confusion to the relatively straightforward clinical diagnosis of CAP and acute asthma and AECB. 
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